Skip Navigation
Health Resources and Services Administration, U.S. Department of Health and Human Services
HHS Logo C.W. Bill Young Cell Transplantation Program - Access to information on bone marrow and cord blood donation and transplantation
  Home | Questions
 


Home > Research, Data and Outcomes > Transplant Data > Registry Transplant Data

Registry Transplant Data

Data about transplants using unrelated marrow donors and cord blood units from the Registry of the C.W. Bill Young Cell Transplantation Program (Registry) are reported annually from October through September.

These data include the number of transplants performed along with the following information:

  • Diagnoses for which transplants have been performed most often, which include blood cancers such as leukemia and lymphoma as well as myelodysplastic syndromes.
  • Cell sources used for transplants, including bone marrow, peripheral blood stem cells (or PBSC) and cord blood.
  • The racial and ethnic heritages of patients who received transplants.
On this page:

Figure 1.


Growth in Number of Registry Transplants


Bar chart showing the growth in number of Registry transplants from 2000 through 2006
View larger image (new window)  Detailed Description [D]

Over the last six years, the number of transplants performed through the Registry has doubled: from 1500 transplants in the year 2000 to more than 3,200 in 2006.

Return to Top

Figure 2.


Registry Transplants by Patient Diagnosis


Bar chart showing the number of Registry transplants by patient diagnosis from 2002 through 2006
View larger image (new window)  Detailed Description [D]

The five diseases for which patients received an unrelated bone marrow or cord blood unit transplant most often during 2006 are listed below.

  • Acute Lymphoblastic Leukemia (ALL): 17% of all transplants  
  • Acute Myelogenous Leukemia (AML): 30% of all transplants
  • Myelodysplastic Syndromes (MDS): 13% of all transplants 
  • Non-Hodgkin’s Lymphoma (NHL): 11% of all transplants 
  • Chronic Myelogenous Leukemia (CML): 5% of all transplants

Since 2000, the numbers of transplants has increased steadily for patients who were diagnosed with AML, MDS, and NHL.

Return to Top

Figure 3.


Registry Transplants by Patient Age

Bar chart showing Registry transplants by patient age in 1997, 2000, 2003 and 2006
View larger image (new window)  Detailed Description [D]

From 1997 through 2006, the number of transplants performed for all age groups increased, with significant growth for patients 50 - 59 years.

Return to Top

Figure 4.

Registry Transplants by Patient Race and Ethnicity



Figure 4a.
American Indian/Alaska Native


Bar chart of transplants for American Indian and Alaska Natvie patients from 2002 through 2006
View larger image (new window)
Detailed Description [D]


Figure 4b.
Asian


Bar chart of transplants for Asian patients from 2002 through 2006
View larger image (new window)
Detailed Description [D]


Figure 4c.
Black/African American


Bar chart of transplants for Black or African American patients from 2002 through 2006
View larger image (new window)
Detailed Description [D]


Figure 4d.
Caucasian


Bar chart of transplants for Caucasian patients from 2002 through 2006
View larger image (new window)
Detailed Description [D]


Figure 4e.
Hispanic/Latino


Bar chart of transplants for Hispanic or Latino patients from 2002 through 2006
View larger image (new window)
Detailed Description [D]


Figure 4f.
Native Hawaiian/Pacific Islander


Bar chart of transplants for Native Hawaiian or Other Pacific Islander patients from 2002 through 2006
View larger image (new window)
Detailed Description [D]

For the last several years, transplants have increased steadily for patients of all racial and ethnic heritages.

Return to Top

Figure 5.

Registry Transplants by Cell Source


Bar chart showing the number of Registry transplants by cell source from 1988 through 2006
View larger image (new window)  Detailed Description [D]

During the year 2006, nearly 450 transplants used cord blood units. Also, more than 850 transplants were performed using bone marrow and nearly 1,900 transplants used peripheral blood stem cells.

Return to Top

Figure 6.


Role of Cord Blood in Registry Transplants for Minority Patients

Pie charts showing the percentage of cord blood transplants versus marrow transplants for minority patients in 2006
View larger image (new window)  Detailed Description [D]

In 2006, cord blood was used to help 26% of minority patients in need of a life-saving transplant.

Return to Top


Last Updated: August 31, 2007

Registry Data
Registry data are reported from Oct. 1 - Sept. 30 by the contractor for the Registry, the National Marrow Donor Program® (NMDP).
Patient Outcomes
Find more information about outcomes using unrelated marrow donors or cord blood units from the Registry.
Successful Outcomes Depend on a Matching Donor
Privacy   |   Accessibility   |   Disclaimers   |   USA.gov   |   Freedom of Information Act   |   Free Acrobat Reader